Decision to list haemodialysis products supplied by BSN Medical Limited
12 December 2018
What we are doing
We are pleased to announce the approval of a listing agreement for a range of haemodialysis products with BSN Medical Limited ("BSN Medical").
In summary this will result in:
- Listing 10 Haemodialysis procedure packs from BSN Medical in Part III of Section H of the Pharmaceutical Schedule from 1 February 2019 under a national agreement that all DHBs may purchase under (“Agreement”).
- DHBs continuing to be able to purchase other suppliers’ brands of haemodialysis products.
Any changes to the original proposal?
No changes have been made to the proposal following consultation.
Who we think will be most interested
- DHB staff
- Haemodialysis staff
- Procurement Officers
- Suppliers and Wholesalers
Detail about this decision
After completing the RFP evaluation processes and consulting on the provisional Agreement reached with BSN Medical, PHARMAC has decided to list BSN Medical’s range of Propax branded procedure packs in Part III of Section H of the Pharmaceutical Schedule from 1 February 2019.
DHBs that purchase BSN Medical haemodialysis products must do so under the terms and conditions, and at the prices, included in the Agreements, from 1 February 2019. DHBs can continue to choose which haemodialysis products they purchase.
Our response to what you told us
We appreciate the time people took to respond to this consultation.
A summary of the main themes raised in feedback and our responses to the feedback received are set out below:
PHARMAC Staff Comment
Ministry of Health advising no technical resource impacts anticipated as a result of proposals
If you have any questions about this decision, you can email us at email@example.com; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.
Last updated: 12 December 2018